About NebulaNeuro, Inc.
NebulaNeuro, Inc. is an early-stage biotechnology company founded in February 2025, led by Professor Read Montague, focused on developing real-time neurotransmitter sensing technology to improve human health and understanding of neurological and psychiatric diseases.
Real-time measurement of neurotransmitters such as dopamine, serotonin, and norepinephrine in the human brainUtilization of artificial intelligence and machine learning for neurochemical signal extractionSub-second, simultaneous measurement of multiple neurotransmittersDevelopment of technology for clinical applications including deep brain stimulation surgery and epilepsy monitoring
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to NebulaNeuro, Inc. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.